ACCEL Lite: AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression
The drug treatments we use to manage atrial fibrillation don't change the progression in the disease. Catheter ablation, even when performed in younger and healthier patients, modifies the disease trajectory and prevents progression.
In this interview, Jason G. Andrade MD, FRCPC and Christopher M. Kramer MD, FACC discuss AHA Late-Breaker: PROGRESSIVE-AF – The Impact of “First-Line” Rhythm Therapy on Atrial Fibrillation Progression.
Related References:
- Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
- Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review
- Atrial Fibrillation Progression After Cryoablation vs. Drug Therapy - will be available same-day as LBCT presentation
Clinical Topics: Arrhythmias and Clinical EP, Atrial Fibrillation/Supraventricular Arrhythmias
Keywords: ACCELLite, Atrial Fibrillation
< Back to Listings